Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal Cancer
2013
Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors
2012
Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors
2015
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Lipid nanoparticle technology for therapeutic gene regulation in the liver
2020
The NOTCH4 – HEY1 Pathway Induces Epithelial–Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
2017
From basic research to clinical development of MEK1/2 inhibitors for cancer therapy
2010
The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis
2018 Standout
ePAD: An Image Annotation and Analysis Platform for Quantitative Imaging
2019
Targeting cancer stem cell pathways for cancer therapy
2020
Targeted therapy of hepatocellular carcinoma: Present and future
2012
MEK in cancer and cancer therapy
2013
Therapeutic modulation of Notch signalling — are we there yet?
2014
Hepatocellular carcinoma
2016 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs
2020
Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future
2016
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
2014
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Shared and Distinct Functions of Type I and Type III Interferons
2019
<p>The journey from gene knockout to clinical medicine: telotristat and sotagliflozin</p>
2019
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
2015
Hepatocellular carcinoma
2021 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Classification and functions of enteroendocrine cells of the lower gastrointestinal tract
2011
Cancer stem cells revisited
2017 Standout
Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
2007
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Preparing Medical Imaging Data for Machine Learning
2020 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation
2014
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Double-balloon endoscopy as the primary method for small-bowel video capsule endoscope retrieval
2010
Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics
2010
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Interventional treatment of neuroendocrine liver metastases
2008
Metabolic reprogramming in macrophage responses
2021
Risk-reduction surgery in pediatric surgical oncology: A perspective
2016
Cisplatin: The first metal based anticancer drug
2019 Standout
Prospects for MEK inhibitors for treating cancer
2014
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Digital pathology and artificial intelligence
2019 Standout
Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration
2021 StandoutNobel
Identifying tumor in pancreatic neuroendocrine neoplasms from Ki67 images using transfer learning
2018
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
2015
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature
2017
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy
2017
Improving anticancer drug development begins with cell culture: misinformation perpetrated by the misuse of cytotoxicity assays
2016
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
ATM Mutations in Cancer: Therapeutic Implications
2016
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Pro (With Caution): Extended oncologic indications in liver transplantation
2017
Combination therapy in combating cancer
2017 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
2011
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
2017 Standout
Unraveling the Anticancer Effect of Curcumin and Resveratrol
2016
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
Diversity of mutations in theRETproto-oncogene and its oncogenic mechanism in medullary thyroid cancer
2015
Combining anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) and -programmed cell death protein 1 (PD-1) agents for cancer immunotherapy
2021
Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells
2016
Works of Jonathan Strosberg being referenced
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study
2020
Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis
2015
A phase II study of RO4929097 in metastatic colorectal cancer
2012
NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors
2010
Update on the Management of Unusual Neuroendocrine Tumors: Pheochromocytoma and Paraganglioma, Medullary Thyroid Cancer and Adrenocortical Carcinoma
2013
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors
2017
Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
2013
Consensus on biomarkers for neuroendocrine tumour disease
2015
The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs)
2010
Evolving Treatment Strategies for Management of Carcinoid Tumors
2013
Phase II Study of the Mitogen-Activated Protein Kinase 1/2 Inhibitor Selumetinib in Patients With Advanced Hepatocellular Carcinoma
2011
Selective Hepatic Artery Embolization for Treatment of Patients with Metastatic Carcinoid and Pancreatic Endocrine Tumors
2006
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
2017
A phase I/II study of TKM-080301, a PLK1-targeted RNAi in patients with adrenocortical cancer (ACC).
2016
Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors
2015
Intermittent Bowel Obstruction Due to a Retained Wireless Capsule Endoscope in a Patient with a Small Bowel Carcinoid Tumour
2007
A phase I dose-escalation study of SCH 900776, a selective inhibitor of checkpoint kinase 1 (CHK1), in combination with gemcitabine (Gem) in subjects with advanced solid tumors.
2010
Neuroendocrine Tumors
2009
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials
2020
Everolimus in advanced, progressive, well‐differentiated, non‐functional neuroendocrine tumors: RADIANT ‐4 lung subgroup analysis
2017
A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High‐grade neuroendocrine neoplasm cohort
2021
A phase II study of AZD6244 in advanced or metastatic hepatocellular carcinoma
2009
Prognostic Validity of the American Joint Committee on Cancer Staging Classification for Midgut Neuroendocrine Tumors
2012
Targeting AKT protein kinase in gastric cancer.
2011
A review of the current clinical trials for gastroenteropancreatic neuroendocrine tumours
2007